Thomas Nerreter
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 21
- CAR-T cell therapy research 16
- Drug Transport and Resistance Mechanisms 3
- Immunology 12
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 3
- Biosimilars and Bioanalytical Methods 2
- Co-authors
- Michael Hudecek (13 shared papers)Hermann Einsele (14 shared papers)Julian Rydzek (4 shared papers)Katrin Mestermann (3 shared papers)Andreas Mades (2 shared papers)Justus Weber (3 shared papers)Theodoros Giavridis (1 shared paper)Silke Frenz (2 shared papers)
- Journals
- Molecular Therapy (2 papers)Leukemia (2 papers)Experimental Hematology (2 papers)Journal of Pharmacy & Pharmaceutical Sciences (2 papers)Blood (2 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Thomas Nerreter
22 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 853
- Immunology 327
- Hematology 138
- Genetics 235
- Structural Biology 11
Countries citing papers authored by Thomas Nerreter
This map shows the geographic impact of Thomas Nerreter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nerreter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nerreter more than expected).
Fields of papers citing papers by Thomas Nerreter
This network shows the impact of papers produced by Thomas Nerreter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nerreter. The network helps show where Thomas Nerreter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Nerreter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells Hit paper breakdown → | 2019 | 379 |
| 2 | 2019 | 154 | |
| 3 | 2018 | 153 | |
| 4 | 2019 | 111 | |
| 5 | 2020 | 53 | |
| 6 | 2018 | 40 | |
| 7 | 2017 | 38 | |
| 8 | 2020 | 38 | |
| 9 | 2014 | 25 | |
| 10 | 2018 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2020 | 17 | |
| 13 | 2014 | 12 | |
| 14 | 2014 | 11 | |
| 15 | 2014 | 9 | |
| 16 | 2025 | 8 | |
| 17 | 2018 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2013 | 5 | |
| 20 | 2017 | 4 |
About Thomas Nerreter
Thomas Nerreter is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Pathology and Forensic Medicine, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Immune Cell Function and Interaction (8 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), Immunotherapy and Immune Responses (4 papers), Virus-based gene therapy research (3 papers), T-cell and B-cell Immunology (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Oncology (853 citations), Immunology (327 citations), Hematology (138 citations), Genetics (235 citations) and Structural Biology (11 citations). Thomas Nerreter has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Michael Hudecek, Hermann Einsele, Julian Rydzek, Katrin Mestermann, Andreas Mades, Justus Weber, Theodoros Giavridis, Silke Frenz, Michel Sadelain and Sören Doose. Their work appears in journals such as Molecular Therapy, Leukemia, Experimental Hematology, Journal of Pharmacy & Pharmaceutical Sciences and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.